ReviewNature reviews. Clinical oncology2025

Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials.

Sophie M Ernst et al.PubMed ↗Publisher ↗

No numbers read from the abstract.